Clinical Trials Browser

Phase 2/3 × Drug Therapy × Head & Neck × Clear all

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Phase 2/3 Completed

Mouth Neoplasms

NCT03344068 2017-12-22

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

Phase 2/3 Unknown

Nasopharyngeal Carcinoma